n | p Value2-150 | ||
---|---|---|---|
Median (range) length of stay (days) | 11 (4, 38) | 29 | |
Months to EF of > 55% (median) | 2.8 (0,28) | 25 | |
Final EF (%) (mean) | 66 (9) | 28 | |
Final SF (%) (mean) | 34 (8) | 27 | |
Most recent Z score | |||
EF | 0.20 (1.24) | 27 | 0.40 |
Z score | ⩽ 2 | 1 | |
SF | −0.02 (2.85) | 26 | 0.98 |
Z score | ⩽ 2 | 5 | |
LVES | −0.12 (2.12) | 20 | 0.81 |
Z score | > 2 | 1 | |
LVED | 0.59 (1.19) | 26 | 0.02 |
Z score | > 2 | 2 | |
LVPW | −1.26 (1.71) | 24 | 0.002 |
Z score | ⩽ 2 | 9 | |
Z score | > 2 | 1 | |
Mean increase in EF (%) | 27 (15) | 25 | < 0.001 |
Mean increase in SF (% ) | 15 (10) | 21 | < 0.001 |
Difference from initial to most recent Z score | |||
EF | 4.27 (1.95) | 25 | < 0.001 |
SF | 7.39 (3.73) | 21 | < 0.001 |
LVES | −3.85 (2.98) | 13 | < 0.001 |
LVED | −1.53 (2.46) | 19 | 0.02 |
LVPW | −1.31 (2.65) | 17 | 0.06 |
ECG normalisation (median) (months) | 3.7 (0, 22) | 27 | |
Median time to discontinuation of medications (months) | 8 (1.6, 32) | 24 | |
Months of follow up (median) | 19 (1.2 ,31.6) | 29 |
↵2-150 p values represent single sample ttest against a hypothesis of a population mean of 0.
EF, ejection fraction; LVED, left ventricular end diastolic dimension; LVES, left ventricular end systolic dimension; LVPW, left ventricular posterior wall thickness; SF, shortening fraction.